- Home
- JAKK vs AQST Comparison
JAKK vs AQST Comparison
Compare JAKK & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- AQST
- Stock Information
- Founded
- JAKK 1995
- AQST 2004
- Country
- JAKK United States
- AQST United States
- Employees
- JAKK N/A
- AQST N/A
- Industry
- JAKK Recreational Games/Products/Toys
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- AQST Health Care
- Exchange
- JAKK Nasdaq
- AQST Nasdaq
- Market Cap
- JAKK 216.9M
- AQST 254.1M
- IPO Year
- JAKK 1996
- AQST 2018
- Fundamental
- Price
- JAKK $19.26
- AQST $2.79
- Analyst Decision
- JAKK Strong Buy
- AQST Strong Buy
- Analyst Count
- JAKK 4
- AQST 5
- Target Price
- JAKK $41.75
- AQST $11.40
- AVG Volume (30 Days)
- JAKK 161.0K
- AQST 939.1K
- Earning Date
- JAKK 04-29-2025
- AQST 05-12-2025
- Dividend Yield
- JAKK 2.57%
- AQST N/A
- EPS Growth
- JAKK 47.04
- AQST N/A
- EPS
- JAKK 4.03
- AQST N/A
- Revenue
- JAKK $714,219,000.00
- AQST $57,561,000.00
- Revenue This Year
- JAKK $2.34
- AQST N/A
- Revenue Next Year
- JAKK $4.14
- AQST $39.51
- P/E Ratio
- JAKK $4.82
- AQST N/A
- Revenue Growth
- JAKK 2.89
- AQST 13.79
- 52 Week Low
- JAKK $17.06
- AQST $2.20
- 52 Week High
- JAKK $35.79
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- JAKK 44.66
- AQST 49.93
- Support Level
- JAKK $17.75
- AQST $2.59
- Resistance Level
- JAKK $19.81
- AQST $3.05
- Average True Range (ATR)
- JAKK 1.11
- AQST 0.16
- MACD
- JAKK 0.28
- AQST 0.00
- Stochastic Oscillator
- JAKK 32.26
- AQST 43.57
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.